Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIAT
Ratios

KalVista Pharmaceuticals (KALV) Long-Term Debt Repayments (2018 - 2020)

Historic Long-Term Debt Repayments for KalVista Pharmaceuticals (KALV) over the last 3 years, with Q2 2020 value amounting to $1000.0.

  • KalVista Pharmaceuticals' Long-Term Debt Repayments fell 9814.81% to $1000.0 in Q2 2020 from the same period last year, while for Apr 2020 it was $54000.0, marking a year-over-year decrease of 7416.27%. This contributed to the annual value of $54000.0 for FY2020, which is 7416.27% down from last year.
  • KalVista Pharmaceuticals' Long-Term Debt Repayments amounted to $1000.0 in Q2 2020, which was down 9814.81% from -$1000.0 recorded in Q1 2020.
  • KalVista Pharmaceuticals' Long-Term Debt Repayments' 5-year high stood at $54000.0 during Q2 2019, with a 5-year trough of -$1000.0 in Q1 2020.
  • Over the past 3 years, KalVista Pharmaceuticals' median Long-Term Debt Repayments value was $52000.0 (recorded in 2018), while the average stood at $40555.6.
  • Its Long-Term Debt Repayments has fluctuated over the past 5 years, first soared by 800.0% in 2019, then plummeted by 10196.08% in 2020.
  • Over the past 3 years, KalVista Pharmaceuticals' Long-Term Debt Repayments (Quarter) stood at $52000.0 in 2018, then increased by 3.85% to $54000.0 in 2019, then crashed by 98.15% to $1000.0 in 2020.
  • Its Long-Term Debt Repayments stands at $1000.0 for Q2 2020, versus -$1000.0 for Q1 2020 and $54000.0 for Q3 2019.